By clicking on the “Submit” button below, you acknowledge that you have read, understand, and agree to be bound by the terms of the QxMD Online Calculator End User Agreement.
Use this calculator to calculate probability of Bone Marrow Involvement in Hodgkin’s Disease.
About this calculator
Although bone marrow involvement is generally rare in Hodgkin’s lymphoma (4% to 14% of patients), the demonstration of involvement has prognostic and therapeutic implications. This clinical prediction rule identifies patients with low, standard, or high-risk for bone marrow involvement. Physicians should make their own decision as to whether a bone marrow biopsy should be completed for each individual patient based on the referral pattern to their hospital and the treatment strategies applied.
In the study reported below, one option suggested by the authors would be to avoid staging bone marrow biopsies in patients in the “low-risk” group, offer a unilateral biopsy in standard-risk patients, and pursue bilateral biopsies in high-risk patients. However, this approach has not been prospectively validated.
This clinical prediction rule is found in: Vassilakopoulos et al. Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma. Blood 105:1875-1880. (2005)
QxMD Hematology contributing author: Dr. Matthew Cheung, MD, SM, FRCP(C)